AURIGENE.AI Trademark

Trademark Overview


On Thursday, April 25, 2024, a trademark application was filed for AURIGENE.AI with the United States Patent and Trademark Office. The USPTO has given the AURIGENE.AI trademark a serial number of 79418528. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, October 14, 2025. This trademark is owned by AURIGENE PHARMACEUTICAL SERVICES LIMITED. The AURIGENE.AI trademark is filed in the Computer & Software Products & Electrical & Scientific Products category with the following description:

Recorded and downloadable computer software specifically designed for drug discovery and pharmaceutical drug development using artificial intelligence; Recorded and downloadable computer software specifically designed for in-vitro experimental testing and diagnostics, in-vivo experimental testing and diagnostics, biomedical diagnosis, molecular structure search, intelligent and novel molecule design, compound library screening, new chemical design prediction, aids in early identification of potential failures, predictive AI models, generative AI models, computational models, computer-aided drug design (CADD) models; all of the foregoing for drug discovery and pharmaceutical drug development using artificial intelligence
aurigene.ai

General Information


Serial Number79418528
Word MarkAURIGENE.AI
Filing DateThursday, April 25, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, October 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the wording "AURIGENE.AI" in black block letters below the stylized letters "AI" in gradient shades of dark blue, light blue, yellow, and green, and within the letters "AI" is a design of stylized thin white lines.
Goods and ServicesRecorded and downloadable computer software specifically designed for drug discovery and pharmaceutical drug development using artificial intelligence; Recorded and downloadable computer software specifically designed for in-vitro experimental testing and diagnostics, in-vivo experimental testing and diagnostics, biomedical diagnosis, molecular structure search, intelligent and novel molecule design, compound library screening, new chemical design prediction, aids in early identification of potential failures, predictive AI models, generative AI models, computational models, computer-aided drug design (CADD) models; all of the foregoing for drug discovery and pharmaceutical drug development using artificial intelligence
Pseudo MarkAI AURIGENE AI ARTIFICIAL INTELLIGENCE AURIGENE.AI
Indication of Colors claimedThe color(s) dark blue, light blue, yellow, green, white, and black is/are claimed as a feature of the mark.
NOT AVAILABLE"AI"

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, March 6, 2025
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAURIGENE PHARMACEUTICAL SERVICES LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIN

Trademark Events


Event DateEvent Description
Thursday, March 6, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Sunday, March 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, March 9, 2025APPLICATION FILING RECEIPT MAILED
Monday, March 10, 2025ASSIGNED TO EXAMINER
Tuesday, April 1, 2025NON-FINAL ACTION WRITTEN
Friday, June 6, 2025REFUSAL PROCESSED BY MPU
Saturday, June 28, 2025REFUSAL PROCESSED BY IB
Thursday, August 28, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 28, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 2, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 6, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 28, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 28, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED